版本:
中国

BRIEF-Mylan says no comment at this point on U.S. generic Advair application

March 29 Mylan:

* Spokeswoman says company has no comment at this point on its U.S. FDA application for generic copy of GlaxoSmithKline's Advair

* For more on this story see Further company coverage: (Reporting by Ben Hirschler)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐